GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for nicotinate phosphoribosyltransferase (A1SVJ9)

Analyse AlphaFold monomer V2.0 prediction for nicotinate phosphoribosyltransferase… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
A1SVJ9
Type
protein
Length
406 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x26D3C47A86831ff95e84759c65F671f9744Fa55e
Molecule
Nicotinate phosphoribosyltransferase
UniProt
A1SVJ9
Pockets
2 · best druggability 0.77

Structure

1 distinct chain · 48% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANicotinate phosphoribosyltransferaseprotein40648% helix, 15% strandA1SVJ9

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15040.770.8561empty
2880.380.7617empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.